Skip to Main Content

Paper Details

Development of Shigella conjugate vaccines targeting Shigella flexneri 2a and S. flexneri 3a using a simple platform-approach conjugation by squaric acid chemistry.
Vaccine
1
2023
Author NameAffiliation
Richelle C CharlesMassachusetts General Hospital, Harvard Medical School, Harvard T.H. Chan School of Public Health
Edward T RyanMassachusetts General Hospital, Harvard Medical School, Harvard T.H. Chan School of Public Health
  • 1 - 2

Datasets

Release 1.2